United Therapeutics (UTHR) Tops Q4 EPS by 60c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $498.48 -0.37%
Revenue Growth %: -1.2%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
USAU, IH, CCL, More
Revenue Growth %: -1.2%
Financial Fact:
Selling, general and administrative: 100.1M
Today's EPS Names:
USAU, IH, CCL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $7.70, $0.60 better than the analyst estimate of $7.10. Revenue for the quarter came in at $790.2 million versus the consensus estimate of $815.24 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Porsche AG (P911:GR) PT Raised to EUR55 at Deutsche Bank
- Axon Enterprise (AXON) Reiterated at Market Outperform by Citizens Amid Public Scrutiny
- INWIT (INW:IM) PT Lowered to EUR9 at Deutsche Bank
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
